Abstract B68: Men at high risk for prostate cancer and the prostate-specific antigen (PSA) test: Uptake levels and physician recommendations

Conclusion: The results of this study add to the argument that although the PSA test is an effective long-term diagnostic tool, it is only being utilized by about 50% of men who meet the criteria for being at high-risk for developing prostate cancer and physicians are only recommending about 59% of these high-risk men. Physicians should be encouraged to pay close attention to men who show signs of increased hereditary risk and recommend them for long-term PSA monitoring and better efforts should be made to educate the high risk community of men about the benefits of non-invasive PSA monitoring.Citation Format: Meshka Anderson, Gwendolyn Quinn, Susan Vadaparampil. Men at high risk for prostate cancer and the prostate-specific antigen (PSA) test: Uptake levels and physician recommendations. [abstract]. In: Proceedings of the Sixth AACR Conference: The Science of Cancer Health Disparities; Dec 6–9, 2013; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2014;23(11 Suppl):Abstract nr B68. doi:10.1158/1538-7755.DISP13-B68
Source: Cancer Epidemiology Biomarkers and Prevention - Category: Cancer & Oncology Authors: Tags: Screening and Early Detection: Poster Presentations - Proffered Abstracts Source Type: research